High-yield dividend stocks like AT&T and Altria are gaining momentum ahead of potential Fed rate cuts, outperforming the S&P 500 this year. Pfizer’s stock is down 13.8%, yielding 6.77%, due to recent struggles and debt from acquisitions. Despite headwinds, Pfizer’s pivot to oncology shows promise. Philip Morris International is leading the tobacco industry’s shift away from cigarettes, with 40% of revenue coming from smoke-free alternatives. Third-quarter net revenue grew 8.4%, with smoke-free products delivering higher revenue. Consider investing $1,000 in Pfizer, as Motley Fool’s Stock Advisor identified it as one of the 10 best stocks for investors right now.

Read more at Nasdaq, Inc.: 2 High-Yield Dividend Stocks I Can’t Stop Buying